Product Description: Nemonoxacin (TG-873870) is an orally active and potent broad-spectrum antibiotic. Nemonoxacin shows good inhibitory activity against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. Nemonoxacin can be used in the study of bacterial infections and community-acquired pneumonia[1][2][3].
Applications: COVID-19-immunoregulation
Formula: C20H25N3O4
References: [1]Adam HJ, et al. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates. Antimicrob Agents Chemother. 2009 Nov;53(11):4915-20. /[2]Li CR, et al. In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone. J Antimicrob Chemother. 2010 Nov;65(11):2411-5. /[3]Lauderdale TL, et al. Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates. Antimicrob Agents Chemother. 2010 Mar;54(3):1338-42.
CAS Number: 378746-64-6
Molecular Weight: 371.43
Compound Purity: 99.80
Research Area: Infection; Inflammation/Immunology
Solubility: DMSO : 2 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Antibiotic;Bacterial
English
Deutsch
